MHRA has issued an alert via the Central Alert System (CAS) for tinzaparin sodium 3,500units in 0.35 ml and 4,500units in 0.45 ml pre-filled syringes.
These will be unavailable between middle of October 2021 and January 2022 (date TBC).
All other presentations of tinzaparin remain unaffected by this supply disruption.
Prescribers should consider the use of alternative low molecular weight heparin (LMWH) for all indications or just for prophylaxis.
Read the alert for further information and action points.